for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-Rigel Makes Statement Regarding Website Error

April 12 (Reuters) - Rigel Pharmaceuticals Inc:

* RIGEL MAKES STATEMENT REGARDING WEBSITE ERROR

* FDA IS CONTINUING ITS REVIEW OF NDA AND PDUFA ACTION DATE FOR FOSTAMATINIB NDA IS APRIL 17

* DUE TO AN ERROR, INACCURATE INFORMATION WAS DISPLAYED REGARDING U.S. FDA’S REVIEW OF NDA FOR FOSTAMATINIB

* CO’S WEBSITE HAS BEEN CORRECTED Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up